Bodybuilding Anabolic Oral Steroid Letrozole Femara 5mg/ml
Letrozole Info
Letrozole CAS: 112809-51-5
Letrozole Molecular Formula: C17H11N5
Letrozole Molecular Weight: 285.31
Letrozole Molecular Structure:
Letrozole White or light yellow crystal
Letrozole Usage: Used as API in Treatment of breast disease.
Letrozole Product features:
Letrozole is approved by the united states food and drug administration (fda) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
Abstrait
Letrozole, an aromatase inhibitor, has been demonstrated to be effective as an ovulation induction and controlled ovarian hyperstimulation agent. Cependant, dose administration has generally been limited to 5 days at 2.5 à 7.5 mg daily. We undertook a retrospective review of over 900 treatment cycles using letrozole in doses as high as 12.5 mg par jour. Results indicate that such doses do indeed offer benefit to patients; in that there is increased follicular growth and a higher number of predicted ovulations with higher doses of the drug.
Cependant, increasing doses does not produce a detrimental effect upon endometrial thickness. High-dose letrozole may be of value in women who fail to respond adequately to lower doses. En outre, randomized trials are needed to determine whether high-dose letrozole might actually be optimal as a starting dose for certain treatment groups.
Femara Letrozole Descrption
1. Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer.
2. For athletes and bodybuilders, Femara is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia.
3. Femara will also raise testosterone levels because of the lowered estrogen in the body.
4. Femara is a new drug developed for the treatment of advanced breast cancer in women.
5. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.
6. Femara acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen.
Directeur commercial